Kruse - centrally activng skeletal muscle relaxants Flashcards

1
Q

Name the spasmolytic with MOA: agonist at GABAB receptors; results in hyperpolarization (due to increased K+ conductance) and inhibition of excitatory neurotransmitter release in the brain and spinal cord

A

baclofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What drug is used to treat reversible spasticity associated with multiple sclerosis or spinal cord lesions with less overall loss of muscle strength than dantrolene

A

baclofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AE of baclofen

A

drowsiness, increased seizure activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Spasmolytic with MOA: CNS depressant, Metabolized to meprobamate, which has anxiolytic and sedative effects

A

carisoprodol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two spasmolytics that are schedule 4 category of controlled drugs?

A

carisoprodol and diazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Use of carisoprodol

A

short term for MSK pain (2-3 weeks)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Use caution when administering what two drugs with CYP450 inhibitors?

A
  • carisoprodol - metabolized by CYP2C19

- cyclobenzaprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drug is ineffective in treating muscle spasm due to cerebral palsy or spinal cord injury

A

cyclobenzaprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What drug related to tricyclic antidepressants and may cause significant sedation, confusion, and transient visual hallucination - why these adverse effects?

A

cyclobenzaprine - produces antimuscarinic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

drowsiness, dizziness, and xerostomia - AE of ___

A

cyclobenzapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drug has MOA: promote binding of GABA (the major inhibitory neurotransmitter in the CNS) to the GABAA receptor, enhancing GABA-induced ion currents (increase frequency of channel openings); leads to increased inhibitory transmission and a reduction in spasticity

A

diazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effect of diazepam at dose required to reduce muscle tone.

A

sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drug is used to tx muscle spasticity and has MOA: alpha2-adrenergic agonist (chemically similar to clonidine) that decreases excitatory input to alpha motor neurons

A

tizanidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dantrolene is CI in pts with ___

A

hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What drug has MOA: cleaves components of the core SNARE complex involved in exocytosis, preventing the release of ACh

A

botulinum toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

four drugs used for Multiple sclerosis

A

glucocorticoids, glatiramer acetate, IFN-B-1a/b, mitoxantrone

17
Q

What drug is used to treat spasticity associated with upper motor neuron disorders (eg, spinal cord injury, stroke, cerebral palsy, or multiple sclerosis)

A

Dantrolene (and management of malignant hyperthermia)

18
Q

What drug class has this use: a. monthly IV bolus of methylprednisolone used to treat primary or secondary progressive MS +/- immunosuppressants

A

Glucocorticoids

19
Q

What drug has MOA: Mixture of four amino acids (L-alanine, L-glutamic acid, L-lysine, and L-tyrosine) - antigenically similar to myelin basic protein, which is an important component of the myelin sheath of nerves
Thought to induce and activate T-lymphocyte suppressor cells specific for a myelin antigen; also proposed to interfere with the antigen-presenting function of certain immune cells opposing pathogenic T-cell function

Used for…

A

Glatiramer acetate

used for relapsing-remitting type MS

20
Q

Drug with MOA: Acts on blood-brain barrier by interfering with T-cell adhesion to the endothelium by binding VLA-4 on T cells or by inhibiting the T-cell expression of MMP

A

IFN-B-1a and IFN-B-1b

21
Q

IFN-B-1a and IFN-B-1b treatment result in…?

A

in a reduction of relapses by one-third, a reduction of new MRI T2 lesions and the volume of enlarging T2 lesions, a reduction in the number and volume of Gd-enhancing lesions, and a slowing of brain atrophy

22
Q

Drug with MOA: Antineoplastic agent used to treat MS, acute myeloid leukemia, and advanced, hormonerefractory prostate cancer

A

mitoxantrone

23
Q

MOA of mitoxantrone

A

intercalates into DNA resulting in cross-links and strand breaks (related to anthracycline antibiotics)